Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Niacin and Statins in Coronary Artery Disease
NCT00431145Phase 2Unknown
- Sponsor
- Ludwig Maximilian University of Munich
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of niacin in coronary artery disease (CAD) (2 arms), sponsored by Ludwig Maximilian University of Munich. Primary endpoints: Number of Endothelial Progenitor Cells at 8 weeks, Inflammatory markers at 8 weeks and 2 more. Status: unknown.
02
Drugs
niacin
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00431145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00431145.